EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review

Shammi Binte Bashar, Zannat Akhter, Bidhan Chandro Saha, Md. Mushfiqul Islam Himaloy, Umme Kulsum, Md. Rashedur Rahman

Pharmacology & Pharmacy · 2022 · 13 (11) · 483-515

DOI: 10.4236/pp.2022.1311036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology & Pharmacy, 2022. Verfasst von Shammi Binte Bashar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bashar, S. B., Akhter, Z., Saha, B. C., Himaloy, M. M. I., Kulsum, U., & Rahman, M. R. (2022). CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review. Pharmacology & Pharmacy, 13(11), 483-515. https://doi.org/10.4236/pp.2022.1311036

Vancouver

Bashar SB, Akhter Z, Saha BC, Himaloy MMI, Kulsum U, Rahman MR. CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review. Pharmacology & Pharmacy. 2022;13(11):483-515. doi:10.4236/pp.2022.1311036

BibTeX
@article{Bashar2022,
  author = {Bashar, Shammi Binte and Akhter, Zannat and Saha, Bidhan Chandro and Himaloy, Md. Mushfiqul Islam and Kulsum, Umme and Rahman, Md. Rashedur},
  title = {CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review},
  journal = {Pharmacology & Pharmacy},
  year = {2022},
  volume = {13},
  number = {11},
  pages = {483--515},
  doi = {10.4236/pp.2022.1311036}
}
Kostenlos starten →